| At the Heart of Healthcare: Addressing the Future of Cardiology Care | 01/10/2021 | |
| Gazing into the Cardiology Crystal Ball: The Future of Preventive Care | | |
| Uncovering Evidence on Blood Pressure Improvements in Americans | | |
| How Does COVID-19 Affect the Heart? | 10/04/2020 | |
| Meet Alan Brown, MD | | |
| Treating Erectile Dysfunction: Key Cardiovascular Considerations | 01/01/2020 | |
| Pharmacometabolomics to Predict Statin Response: Ready for Prime Time? | 12/24/2019 | |
| Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines | 12/06/2019 | |
| PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects | 12/12/2019 | |
| Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease | 12/19/2019 | |
| Canadian Perspectives on Managing Lipid Disorders in Children | 12/26/2019 | |
| Lipid-Lowering Drug Interactions in Cardiovascular Agents | 01/06/2020 | |
| Selecting the Right Contraception for the Dyslipidemic Woman | 01/15/2021 | |
| Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross | 01/07/2020 | |
| Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide | 11/15/2018 | |
| Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies | 02/27/2018 | |
| What's the Deal with Saturated Fat and Cardiovascular Disease Risk? | 03/01/2018 | |
| Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines | 08/10/2019 | |
| The Lipidology Essentials: Making of a Specialty's Annual Summary | 01/12/2020 | |
| Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide? | 03/29/2018 | |
| Pathways Toward Better Lipid Medication Adherence | 12/07/2017 | |
| Special Populations in Patient-Centered Management of Dyslipidemia | 01/02/2018 | |
| Dyslipidemia in The Elderly: How Old is "Too Old" to Treat? | 08/29/2019 | |
| Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV | 01/25/2018 | |
| Updated NLA Recommendations for African American Patients | 05/16/2018 | |
| Dyslipidemia in Children and Adolescents | 01/22/2018 | |
| Million Hearts Initiative with Dr. Janet Wright, Executive Director | 01/29/2018 | |
| Dyslipidemia During Pregnancy: The Risks for Two Patients | 06/15/2018 | |
| Statin Intolerance: Keys to Patient Counseling and Guidance | 01/31/2018 | |
| Roles of Non-HDL Cholesterol in Risk Assessment and Treatment | 09/19/2017 | |
| Keys to the Latest NLA Recommendations for Dyslipidemia Treatments | 02/01/2018 | |
| Management of the Patient With Triglycerides 200-499 mg/dl. | 09/21/2017 | |
| What is the Safety of Statins in Patients with Diabetes? | 09/27/2017 | |
| A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines | 11/20/2017 | |
| National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia | 12/18/2017 | |
| New Insights on Statin Therapy for Older Patients | 10/05/2017 | |
| HPS-2 THRIVE Data and Results | 10/19/2017 | |
| Health Information Technology's Impact on Adherence to Lipid Therapy | 10/10/2017 | |
| Cardiometabolic Consequences of Sitting Time | 03/17/2016 | |
| Generics and Manufacturing: What Prescribers Need to Know | 10/26/2017 | |
| Genetic Testing for Familial Hypercholesterolemia | 01/08/2016 | |
| Research Updates in Familial Hypercholesterolemia | 02/24/2016 | |
| Research Updates on Postprandial Dyslipidemia Treatment | 02/25/2016 | |
| Lipid Biomarker Updates: When to Move Beyond the Standard Profile | 02/25/2016 | |
| What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Pat... | 10/13/2015 | |
| Adiposity, Obesity, and Dyslipidemia | 02/18/2016 | |
| Researching Oxidized High-Density Lipoprotein in Obese Adolescents | 08/29/2016 | |
| Underrecognition of Diabetes in Cardiology Practice | 02/19/2016 | |
| An Avocado a Day: Does It Keep Heart Disease Away? | 02/26/2016 | |
| The Impact of Inflammation on HDL Activity | 09/27/2016 | |
| Changing Nutritional Needs Throughout the Lifetime | 11/19/2015 | |
| Managing CVD in Women During Childbearing Years | 09/03/2015 | |
| Obesity, Diabetes and the Metabolic Syndrome | 03/06/2015 | |
| Broken Hearts or Broken Bones? | 11/17/2015 | |
| Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes | 09/25/2015 | |
| Evolving Treatments: A Review of What’s in the Pipeline | 06/14/2013 | |
| Fish Oils: Are They Still Cardioprotective? | 07/05/2013 | |
| Treatment Options for Polycystic Ovarian Syndrome (PCOS) | 04/20/2018 | |
| Controversy Surrounding the NHLBI Pediatric Guidelines | 04/03/2015 | |
| Statin Safety Considerations | 08/23/2013 | |
| Emerging LDL Therapies | 04/10/2015 | |
| Emerging HDL Therapies: What’s Next on the Clinical Research Horizon | 03/20/2015 | |
| Understanding Why Patients Discontinue Statin Therapy | 05/08/2015 | |
| Statin Therapy and Diabetes Incidence | 08/28/2015 | |
| Lipids and Hormone Therapy | 03/01/2013 | |
| Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention | 02/22/2013 | |
| Biomarkers and Lipidology | 03/08/2013 | |
| Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia | 02/15/2013 | |
| Fat, Exercise and Cholesterol | 03/22/2018 | |
| Managing Lipids in the Chronic Kidney Disease Patient | 04/05/2018 | |
| Coronary CT Angiography | 08/16/2013 | |
| Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease | 07/12/2013 | |
| Management Issues in Familial Hypercholesterolemia | 09/29/2016 | |
| Familial Hypercholesterolemia: Risk Stratifications in Practice | 09/20/2013 | |
| From Experts to Analytics: What Does Evidence-Based Medicine Mean? | 01/25/2013 | |
| CIMT Appropriate Use Guidelines | 08/09/2013 | |
| Personalizing Dietary Approaches for Cardiovascular Health | 08/02/2013 | |
| LDL Apheresis | 10/04/2016 | |
| Imaging Guidelines for Screening CV Risk | 06/15/2012 | |
| Fundamentals of Fatty Acids | 06/08/2012 | |
| It's Relative: Screening and Treating Familial Hypercholesterolemia | 06/22/2012 | |
| Caring for Un- and Under-Insured Patients on Lipid Therapy | 09/13/2016 | |
| Current Inquiries in Lipidology: The NLA's Role in the Field | 06/03/2011 | |
| Predictive Value of Lipid Biomarkers and Inflammatory Markers | 05/06/2011 | |
| The Importance of Omega-3 Fatty Acids | 04/29/2011 | |
| Metabolic Syndrome in African Americans: Risk Adjustments & Treatments | 04/22/2011 | |
| Atherosclerosis and Cardiovascular Risk Factors in Children | 04/15/2011 | |
| Cardiometabolic Risk Reduction in Native Americans | 04/01/2011 | |
| The Process of Developing Clinical Guidelines | 10/08/2010 | |
| Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting | 10/01/2010 | |
| Lipid Management and Systemic Approaches to Patient Care | 09/10/2010 | |
| Heart Disease in the United States: Past, Present, and Future Trends | 10/15/2010 | |
| Behavioral Strategies for Managing Weight | 03/11/2011 | |
| Exercise as Medicine | 03/25/2011 | |
| Using HDL in the Clinical Setting | 12/24/2010 | |
| Particle Number Testing in the Prevention of Atherosclerosis | 03/26/2010 | |
| Strategies to Help Reduce Diseases Associated with Lifestyle | 03/25/2016 | |
| Reevaluating Heart Protective vs Destructive Dietary Fats | 03/04/2011 | |
| Dietary Fats and Cardiovascular Disease | 08/20/2010 | |
| Looking Beyond LDL to Reduce Cardiovascular Events | 11/02/2008 | |
| The Latest Targets of Lipid Therapy | 09/07/2008 | |
